Compare VALE & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VALE | ELV |
|---|---|---|
| Founded | 1942 | 1944 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Medical Specialities |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.3B | 86.6B |
| IPO Year | 2008 | 2001 |
| Metric | VALE | ELV |
|---|---|---|
| Price | $15.19 | $403.56 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 19 |
| Target Price | $16.96 | ★ $383.56 |
| AVG Volume (30 Days) | ★ 24.0M | 910.3K |
| Earning Date | 05-12-2026 | 04-22-2026 |
| Dividend Yield | ★ 5.71% | 1.83% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 14.73 |
| Revenue | N/A | ★ $199,125,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.07 |
| P/E Ratio | $29.09 | ★ $27.08 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $10.08 | $274.89 |
| 52 Week High | $17.94 | $436.24 |
| Indicator | VALE | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 61.89 | 58.06 |
| Support Level | $14.68 | $382.77 |
| Resistance Level | $17.19 | $406.36 |
| Average True Range (ATR) | 0.34 | 8.58 |
| MACD | 0.15 | 1.40 |
| Stochastic Oscillator | 95.90 | 95.34 |
Vale is a large global miner and the world's largest producer of iron ore and pellets. In recent years the company has sold noncore assets such as its fertilizer, coal, and steel operations to concentrate on iron ore, nickel, and copper. Earnings are dominated by its iron ore business. The base metals division is much smaller, consisting of nickel mines and smelters along with copper mines producing copper in concentrate. In 2024, Vale sold a minority 10% stake in its base metals business, likely the first step in separating base metals and iron ore.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.